Stock listing

Vitrolife Ab

Selected listing: A2JLT3 · LS · EUR · DE

Vitrolife Ab (Lang & Schwarz: A2JLT3), Health Technology. Latest release Jul 16, 2026: Interim report Q2, 2026: Strong margins and high profitability in soft…

A2JLT3:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A2JLT3
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Vitrolife Ab

Interim report Q2, 2026: Strong margins and high profitability in soft market conditions

July 16, 2026

Vitrolife Group launches SEK 500 million share repurchase programme

July 15, 2026

Vitrolife Group appoints Olivier Desmarets as Chief Operations Officer following Ermanno Sironi's retirement

June 1, 2026

CEO Bronwyn Brophy O'Connor has decided to leave Vitrolife Group

May 22, 2026

Vitrolife : Appendix 2 - Proposed Agenda

May 19, 2026

All Vitrolife Ab news →

Events

Replays

Vitrolife AB (publ) (VITR) Q2 2026 Earnings Call
Thu, Jul 16, 2026 · 04:00 AM ET
Watch
Vitrolife AB (publ) (VITR) Q1 2026 Earnings Call
Thu, Apr 23, 2026 · 04:00 AM ET
Watch
Vitrolife AB (publ) (VITR) Q4 2025 Earnings Call
Tue, Feb 03, 2026 · 04:00 AM ET
Watch

Research Vitrolife Ab

Vitrolife Ab company profile

View the public company page for Vitrolife Ab on 6ix.

Vitrolife Ab news

Read company news and market updates connected to Vitrolife Ab.

Vitrolife Ab investor events

Find investor webinars, events, and replay context for Vitrolife Ab.